KABRA DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 ,inter alia, to consider and approve This is to inform you that the meeting of the Board of Directors of the Company in convened on Thursday, 30th May, 2024 at registered office at 05.00 p.m. to transact the business as given below:\r\n 1. To consider and approve the audited financial results for the quarter and the year ended on 31st March, 2024 pursuant to regulation 33 of SEBI (Listed Obligations and Disclosure Requirements) Regulations, 2015;\r\n 2. To consider any other matter with the permission of the Chairman of the meeting.\r\n\r\nNote: The trading window for dealing in shares in the Company for all the promoters, directors, designated employees, and the concerned connected persons has been closed till 48 hours of the announcement of the financial results.